FBI arrests Pharma CEO Martin Shkreli on securities fraud charges

FBI arrests Pharma CEO Martin Shkreli on securities fraud charges

The pharmaceutical company CEO who became infamous after hiking the price of an HIV drug from $13.50 to $750 per pill has been arrested by the FBI on securities fraud charges, law enforcement sources said.

The arrest of Martin Shkreli comes amid an investigation related to a hedge fund and drug company he once ran, Reuters reported.

Shkreli, 32, who was taken into custody at his New York City residence, is currently the boss of Turing Pharmaceuticals. He was previously the manager of hedge fund MSMB Capital Management and chief executive of biopharmaceutical company Retrophin Inc.

Shkreli this year became a lightning rod for growing outrage over the soaring prices of prescription drugs.

Bütün xəbərlər Facebook səhifəmizdə